127 investors boost Raleigh firm creating alternative to EpiPen funding to $26M
Investors continue to pour money into Bryn Pharma, the Raleigh-based startup developing an alternative to the EpiPen. Here’s an update.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed